Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- Check4 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check11 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe study page now displays a 403 error page instead of the study record details. This indicates the page is currently inaccessible.SummaryDifference17%

- Check54 days agoChange DetectedA funding attribution note for the 2016 U.S. NIH grant/contract was added. The page revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision indicator changed from v3.6.4 to v3.6.5, reflecting a background update to the ClinicalTrials.gov interface while the study details remain the same.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision label on the page updated from v3.6.3 to v3.6.4. This reflects a software update to the site rather than a modification to the study information or user-facing content.SummaryDifference0.1%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.